Inhibition of Bruton's tyrosine kinase selectively prevents antigen-activation of B cells and ameliorates B cell-mediated experimental autoimmune encephalomyelitis

被引：0
|
作者：
Torke, S. [1 ]
Greeningloh, R. [2 ]
Boschert, U. [2 ]
Weber, M. [3 ,4 ]
机构：
[1] Inst Neruopathol, Editorial, Gottingen, Germany
[2] EMD Serono Res & Dev Inst, Billerica, MA USA
[3] Univ Med Ctr, Inst Neuropathol, Gottingen, Germany
[4] Univ Med Ctr Gottingen, Dept Neurol, Gottingen, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2018年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P575
引用
收藏
页码：276 / 276
页数：1
相关论文
共 50 条
  • [21] MONITORING B CELL ACTIVATION BY FLOW CYTOMETRIC DETECTION OF PHOSPHORYLATED BRUTON'S TYROSINE KINASE (BTK)
    Li, X.
    Marchini, T.
    Westermann, D.
    Wolf, D.
    ATHEROSCLEROSIS, 2023, 379 : S43 - S44
  • [22] Mature anti-insulin B cells survive and present antigen in the absence of Bruton's tyrosine kinase
    Nyhoff, Lindsay E.
    Clark, Emily S.
    Khan, Wasif N.
    Kendall, Peggy L.
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [23] Posttranscriptional regulation of Bruton's tyrosine kinase expression in antigen receptor-stimulated splenic B cells
    Nisitani, S
    Satterthwaite, AB
    Akashi, K
    Weissman, IL
    Witte, ON
    Wahl, MI
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (06) : 2737 - 2742
  • [24] Amelioration of a cell-mediated autoimmune eye disease by targeting the uveitogenic antigen to B cells.
    Kozhich, AT
    Whitcup, SM
    Gery, I
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1997, 38 (04) : 2069 - 2069
  • [25] The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy
    Honigberg, Lee A.
    Smith, Ashley M.
    Sirisawad, Mint
    Verner, Erik
    Loury, David
    Chang, Betty
    Li, Shyr
    Pan, Zhengying
    Thamm, Douglas H.
    Miller, Richard A.
    Buggy, Joseph J.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (29) : 13075 - 13080
  • [26] TARGETING AUTOANTIGEN TO B-CELLS PREVENTS THE INDUCTION OF A CELL-MEDIATED AUTOIMMUNE-DISEASE IN RATS
    DAY, MJ
    TSE, AGD
    PUKLAVEC, M
    SIMMONDS, SJ
    MASON, DW
    JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (03): : 655 - 659
  • [27] Structural Complementarity of Bruton's Tyrosine Kinase and Its Inhibitors for Implication in B-Cell Malignancies and Autoimmune Diseases
    Najmi, Asim
    Thangavel, Neelaveni
    Mohanan, Anugeetha Thacheril
    Qadri, Marwa
    Albratty, Mohammed
    Ashraf, Safeena Eranhiyil
    Saleh, Safaa Fathy
    Nayeem, Maryam
    Mohan, Syam
    PHARMACEUTICALS, 2023, 16 (03)
  • [28] Prolonged Inhibition of BCR Signaling and Suppression of B Cell Lymphoma through Irreversible Inhibition of Bruton's Tyrosine Kinase.
    Evans, Erica
    Sheets, Michael
    Bernard, Hugues
    Martin, Thia St.
    Nacht, Mariana
    Tester, Rich
    Jewell, Chuck
    Mazdiyasni, Hormoz
    Petter, Russell
    Westlin, William
    Singh, Juswinder
    BLOOD, 2008, 112 (11) : 904 - 904
  • [29] Activation of NF-κB in B cell receptor signaling through Bruton's tyrosine kinase-dependent phosphorylation of IκB-α
    Pontoriero, Marilena
    Fiume, Giuseppe
    Vecchio, Eleonora
    de Laurentiis, Annamaria
    Albano, Francesco
    Iaccino, Enrico
    Mimmi, Selena
    Pisano, Antonio
    Agosti, Valter
    Giovannone, Emilia
    Altobelli, Annalisa
    Caiazza, Carmen
    Mallardo, Massimo
    Scala, Giuseppe
    Quinto, Ileana
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2019, 97 (05): : 675 - 690
  • [30] Bruton's tyrosine kinase is required for signaling the CD79b-mediated pro-B to pre-B cell transition
    Kouro, T
    Nagata, K
    Takaki, S
    Nisitani, S
    Hirano, R
    Wahl, MI
    Witte, ON
    Karasuyama, H
    Takatsu, K
    INTERNATIONAL IMMUNOLOGY, 2001, 13 (04) : 485 - 493
12345